CSIMarket


American Bio Medica Corporation  (ABMC)
Other Ticker:  
 

American Bio Medica Corporation

ABMC's Fundamental analysis








American Bio Medica's sales fell by -53.28 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 3926

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.33 %

American Bio Medica realized net income compared to net loss a year ago in I. Quarter 2023

More on ABMC's Growth


American Bio Medica
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 0.09 in trailing twelve-month period.
Company
-
PE TTM   
Industry
283.72
PE TTM    
Company's Price to Sales ratio is at 0.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.79.


More on ABMC's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 9.91
 Tangible Book Value (Per Share $) -0.01

American Bio Medica
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 0.09 in trailing twelve-month period.
Company
-
PE TTM   
Industry
283.72
PE TTM    
Company's Price to Sales ratio is at 0.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.79.


More on ABMC's Valuation

  Market Capitalization (Millions $) 0
  Shares Outstanding (Millions) 48
  Employees -
  Revenues (TTM) (Millions $) 1
  Net Income (TTM) (Millions $) 1
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 9.91
  Tangible Book Value (Per Share $) -0.01

  Market Capitalization (Millions $) 0
  Shares Outstanding (Millions) 48
  Employees -
  Revenues (TTM) (Millions $) 1
  Net Income (TTM) (Millions $) 1
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 0.59
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.61
  Inventory Turnover Ratio (TTM) -





American Bio Medica net profit margin of 1146.95 % is currently ranking no. 1 in Major Pharmaceutical Preparations industry, ranking no. 3 in Healthcare sector and number 25 in S&P 500.

More on ABMC's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com